IGM Biosciences CEO sells shares value over $45,000 By Investing.com
IGM Biosciences, Inc. (NASDAQ:) CEO and President Fred Schwarzer has offered a…
BofA flags investor doubts as Arcus Biosciences inventory struggles By Investing.com
On Friday, BofA Securities revised its worth goal for Arcus Biosciences (NYSE:),…
Senhwa Biosciences receives US FDA Examine Might Proceed letter for the Part I/II examine of Silmitasertib (CX-4945) together with chemotherapy in kids and younger adults with relapsed refractory s By Investing.com
TAIPEI and SAN DIEGO, Aug. 6, 2024 /PRNewswire/ -- Senhwa Biosciences, Inc.…
Tyra Biosciences hits 52-week excessive, reaching $21.67 By Investing.com
Tyra Biosciences, a number one biotechnology firm, has reached a brand new…
